352 related articles for article (PubMed ID: 32599245)
41. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
42. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Zhang Q; Bastard P; Liu Z; Le Pen J; Moncada-Velez M; Chen J; Ogishi M; Sabli IKD; Hodeib S; Korol C; Rosain J; Bilguvar K; Ye J; Bolze A; Bigio B; Yang R; Arias AA; Zhou Q; Zhang Y; Onodi F; Korniotis S; Karpf L; Philippot Q; Chbihi M; Bonnet-Madin L; Dorgham K; Smith N; Schneider WM; Razooky BS; Hoffmann HH; Michailidis E; Moens L; Han JE; Lorenzo L; Bizien L; Meade P; Neehus AL; Ugurbil AC; Corneau A; Kerner G; Zhang P; Rapaport F; Seeleuthner Y; Manry J; Masson C; Schmitt Y; Schlüter A; Le Voyer T; Khan T; Li J; Fellay J; Roussel L; Shahrooei M; Alosaimi MF; Mansouri D; Al-Saud H; Al-Mulla F; Almourfi F; Al-Muhsen SZ; Alsohime F; Al Turki S; Hasanato R; van de Beek D; Biondi A; Bettini LR; D'Angio' M; Bonfanti P; Imberti L; Sottini A; Paghera S; Quiros-Roldan E; Rossi C; Oler AJ; Tompkins MF; Alba C; Vandernoot I; Goffard JC; Smits G; Migeotte I; Haerynck F; Soler-Palacin P; Martin-Nalda A; Colobran R; Morange PE; Keles S; Çölkesen F; Ozcelik T; Yasar KK; Senoglu S; Karabela ŞN; Rodríguez-Gallego C; Novelli G; Hraiech S; Tandjaoui-Lambiotte Y; Duval X; Laouénan C; ; ; ; ; ; ; ; ; Snow AL; Dalgard CL; Milner JD; Vinh DC; Mogensen TH; Marr N; Spaan AN; Boisson B; Boisson-Dupuis S; Bustamante J; Puel A; Ciancanelli MJ; Meyts I; Maniatis T; Soumelis V; Amara A; Nussenzweig M; García-Sastre A; Krammer F; Pujol A; Duffy D; Lifton RP; Zhang SY; Gorochov G; Béziat V; Jouanguy E; Sancho-Shimizu V; Rice CM; Abel L; Notarangelo LD; Cobat A; Su HC; Casanova JL
Science; 2020 Oct; 370(6515):. PubMed ID: 32972995
[TBL] [Abstract][Full Text] [Related]
43. Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.
Cavalli E; Petralia MC; Basile MS; Bramanti A; Bramanti P; Nicoletti F; Spandidos DA; Shoenfeld Y; Fagone P
Int J Mol Med; 2020 Oct; 46(4):1266-1273. PubMed ID: 32945352
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
Zhang C; Feng YG; Tam C; Wang N; Feng Y
Front Immunol; 2021; 12():733171. PubMed ID: 34880855
[TBL] [Abstract][Full Text] [Related]
45. Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma.
Zhou X; Huang T; Pan H; Du A; Wu T; Lan J; Song Y; Lv Y; He F; Yuan K
PLoS One; 2024; 19(4):e0300441. PubMed ID: 38648205
[TBL] [Abstract][Full Text] [Related]
46. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
Di Giorgio S; Martignano F; Torcia MG; Mattiuz G; Conticello SG
Sci Adv; 2020 Jun; 6(25):eabb5813. PubMed ID: 32596474
[TBL] [Abstract][Full Text] [Related]
47. Consensus transcriptional regulatory networks of coronavirus-infected human cells.
Ochsner SA; Pillich RT; McKenna NJ
Sci Data; 2020 Sep; 7(1):314. PubMed ID: 32963239
[TBL] [Abstract][Full Text] [Related]
48. A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?
Saulle I; Vanetti C; Goglia S; Vicentini C; Tombetti E; Garziano M; Clerici M; Biasin M
Cells; 2020 Aug; 9(9):. PubMed ID: 32847031
[TBL] [Abstract][Full Text] [Related]
49. Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology.
Kole A; Bag AK; Pal AJ; De D
BMC Bioinformatics; 2024 Feb; 25(1):74. PubMed ID: 38365632
[TBL] [Abstract][Full Text] [Related]
50. A Surface Coating that Rapidly Inactivates SARS-CoV-2.
Behzadinasab S; Chin A; Hosseini M; Poon L; Ducker WA
ACS Appl Mater Interfaces; 2020 Aug; 12(31):34723-34727. PubMed ID: 32657566
[TBL] [Abstract][Full Text] [Related]
51. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
[TBL] [Abstract][Full Text] [Related]
52. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
Chen N; Zhang B; Deng L; Liang B; Ping J
Emerg Microbes Infect; 2022 Dec; 11(1):1371-1389. PubMed ID: 35476817
[TBL] [Abstract][Full Text] [Related]
53. Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches.
Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
F1000Res; 2021; 10():127. PubMed ID: 33968364
[No Abstract] [Full Text] [Related]
54. Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection.
Toro A; Lage-Vickers S; Bizzotto J; Vilicich F; Sabater A; Pascual G; Ledesma-Bazan S; Sanchis P; Ruiz MS; Arevalo AP; Porfido JL; Abbate M; Seniuk R; Labanca E; Anselmino N; Navone NM; Alonso DF; Vazquez E; Crispo M; Cotignola J; Gueron G
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298734
[TBL] [Abstract][Full Text] [Related]
55. Differentially expressed immune response genes in COVID-19 patients based on disease severity.
Li S; Duan X; Li Y; Li M; Gao Y; Li T; Li S; Tan L; Shao T; Jeyarajan AJ; Chen L; Han M; Lin W; Li X
Aging (Albany NY); 2021 Mar; 13(7):9265-9276. PubMed ID: 33780352
[TBL] [Abstract][Full Text] [Related]
56. Predicted SARS-CoV-2 miRNAs Associated with Epigenetic Viral Pathogenesis and the Detection of New Possible Drugs for Covid-19.
Çetin Z; Bayrak T; Oğul H; Saygılı Eİ; Akkol EK
Curr Drug Deliv; 2021; 18(10):1595-1610. PubMed ID: 33645482
[TBL] [Abstract][Full Text] [Related]
57. Repurposing of thalidomide and its derivatives for the treatment of SARS-coV-2 infections: Hints on molecular action.
Sundaresan L; Giri S; Singh H; Chatterjee S
Br J Clin Pharmacol; 2021 Oct; 87(10):3835-3850. PubMed ID: 33609410
[TBL] [Abstract][Full Text] [Related]
58. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.
Politano G; Benso A
PLoS Comput Biol; 2020 Sep; 16(9):e1008238. PubMed ID: 32997660
[TBL] [Abstract][Full Text] [Related]
59. Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients.
Huang B; Huang J; Chiang NH; Chen Z; Lui G; Ling L; Kwan MYW; Wong JSC; Mak PQ; Ling JWH; Lam ICS; Ng RWY; Wang X; Gao R; Hui DS; Ma SL; Chan PKS; Tang NLS
Front Immunol; 2023; 14():1315602. PubMed ID: 38268924
[TBL] [Abstract][Full Text] [Related]
60. Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.
Chen X; Saccon E; Appelberg KS; Mikaeloff F; Rodriguez JE; Vinhas BS; Frisan T; Végvári Á; Mirazimi A; Neogi U; Gupta S
Cell Death Discov; 2021 May; 7(1):114. PubMed ID: 34006825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
